Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study. Schwid SR, Thorpe J, Sharief M, Sandberg-Wollheim M, Rammohan K, Wendt J, Panitch H, Goodin D, Li D, Chang P, et al. Arch Neurol. 2005 May; 62(5):785-92. PMID: 15883267. Abstract CommentRecommendBookmarkWatch